Trials / Completed
CompletedNCT00678184
The Effect of Atorvastatin on Renal Function in Healthy Subjects During Normal and High Sodium Intake
The Effect of Acute HMG-CoA-Reductase Inhibition (Atorvastatin) on Renal Sodium Excretion, Renal Hemodynamics, Tubular Function and Vasoactive Hormones in Healthy Subjects During Normal and High Sodium Intake
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 23 (actual)
- Sponsor
- Regional Hospital Holstebro · Academic / Other
- Sex
- All
- Age
- 20 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
We wanted to test the hypothesis that acute treatment with atorvastatin changes renal sodium handling, renal hemodynamics, tubular function and vasoactive hormones in healthy humans during normal and high sodium intake.
Detailed description
We wanted to test the hypothesis that acute treatment with atorvastatin changes renal sodium handling, renal hemodynamics, tubular function and vasoactive hormones in healthy humans during normal and high sodium intake. We wanted to analyze if changes in renal hemodynamics, tubular function, hormones, blood pressure and HR under acute treatment with atorvastatin depends on sodium intake.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Atorvastatin | 80 mg atorvastatin on two following days each |
Timeline
- Start date
- 2007-01-01
- Primary completion
- 2007-10-01
- Completion
- 2007-10-01
- First posted
- 2008-05-15
- Last updated
- 2008-05-15
Locations
2 sites across 1 country: Denmark
Source: ClinicalTrials.gov record NCT00678184. Inclusion in this directory is not an endorsement.